Pharmalittle: We’re reading about weight loss drug spending, launch prices for medicines, and much more
Top of the morning to you, and a fine one it is. Clear, blue skies and mild breezes…
Cadence raises $100 million to automate chronic disease care with regulated AI
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech;…
AI Prognosis: Your sepsis algorithm shouldn’t require a time machine
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
ASCO News: Bristol and Pfizer report favorable results — Day 1
Chicago, where thousands in the cancer world gather each year.Adam Feuerstein/STAT Adam Feuerstein is a senior writer and…
European Union inks draft deal to boost local production of drug, avoid shortages
The European Union reached a provisional deal to strengthen the supply of essential medicines — such as antibiotics,…
Capricor Therapeutics accuses Nippon Shinyaku of slow-walking Duchenne drug
Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for…
Hospitals launch chatbots, creating another funnel for patient intake
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Insurers, hospitals agree AI scribes raise medical bills. What now?
To hear health systems tell the story, artificial intelligence tools like ambient scribes are helping not only reduce…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
How Hims has transformed medicine in a few short years
As the Super Bowl approached halftime, Hims & Hers publicly staked its claim to preventive medicine in front…